Eu funds for cancer research

Eu funds for cancer research

A preliminary announcement for the first Translational Cancer Research (TRANSCAN) joint transnational call for proposals has been published. The topic of the call will be 'validation of biomarkers for personalised cancer medicine'.

The call will seek to develop transnational innovative projects in oncology, clearly oriented towards a rapid application of new and more selective and effective tools and strategies for the prevention, diagnosis and early detection, as well as optimising therapy of neoplastic diseases.

The ERA-NET on Translational Cancer Research (TRANSCAN) was established to coordinate the research efforts and funding programmes of European countries in translational cancer research.

Research projects submitted within this call must be based on novel ideas stemming from fairly advanced results, allowing for concrete progress in the validation of the candidate biomarkers. In general, the research projects should fall either stem from previous laboratory and/or early phase clinical investigations or come from fairly advanced clinical investigations.

The research proposals should also be built on an effective, multidisciplinary and multi-professional collaboration between academic, clinical, epidemiological or public health research teams and industry. The research teams within a consortium should include investigators of all scientific disciplines, research areas and expertises necessary to achieve the proposed objectives. The sharing of relevant results, data sets and/or resources within international research consortia will be a prerequisite for funding.

The following partner organisations have agreed to participate in the call:

- Austrian Science Fund (FWF), Austria;

- Research Foundation Flanders (FWO), Belgium;

- National Cancer Institute (INCa), France;

- Federal Ministry of Education and Research (BMBF), Germany;

- General Secretariat for Research and Technology, Ministry of Education, Life-long Learning and Religious Affairs (GSRT), Greece;

- Chief Scientist Office of the Ministry of Health (CSO-MOH), Israel;

- Ministry of Health (MOH), Italy;

- Latvian Academy of Science (LAS), Latvia;

- National Centre for Research and Development (NCBiR), Poland;

- Institute of Oncology (IOB), Romania;

- Slovak Academy of Sciences (SAS), Slovakia;

- Ministry of Higher Education, Science and Technology (MHEST), Slovenia;

- Institute of Health Carlos III (ISCIII), Spain;

- Scientific and Technological Research Council of Turkey (TÜBITAK), Turkey.

The call will be published simultaneously by the funding organisations in their respective countries and coordinated centrally by the Joint Call Secretariat (JCS).

Receive the pre-announcement in your email box